Yes, Singapore offers accelerated pathways for drug registration, including the Priority Review and the New Drug Application (NDA) routes. These pathways expedite the evaluation process for drugs addressing unmet medical needs or offering significant therapeutic benefits, ensuring faster access to innovative treatments... Read More
The ASEAN Common Technical Dossier (ACTD) in Singapore streamlines the drug registration process by standardizing documentation requirements across ASEAN member states. It facilitates efficient evaluation and approval of pharmaceuticals, ensuring safety, quality, and efficacy. This harmonization reduces administrative burdens, accelerates market access,... Read More
Singaporean regulatory updates can significantly impact ongoing drug registrations by altering compliance requirements, timelines, and approval processes. Companies must adapt to new guidelines, which may involve additional data submissions or revised safety protocols. Staying informed and agile ensures alignment with Health Sciences... Read More
Singapore regulates traditional medicines through the Health Sciences Authority (HSA). While traditional medicines are generally not required to be registered, they must comply with safety and quality standards. Manufacturers and importers are responsible for ensuring products are free from harmful substances and... Read More
Malaysia Drug Registration is the process by which pharmaceutical products are evaluated and approved by the National Pharmaceutical Regulatory Agency (NPRA) to ensure their safety, efficacy, and quality. This involves a thorough review of documentation, clinical data, and compliance with regulatory standards... Read More
In Malaysia, the National Pharmaceutical Regulatory Agency (NPRA), under the Ministry of Health, oversees drug registration. The NPRA evaluates the safety, efficacy, and quality of pharmaceutical products before granting approval. It ensures compliance with regulatory standards, safeguarding public health by monitoring and... Read More
The National Pharmaceutical Regulatory Agency (NPRA) ensures the safety, efficacy, and quality of pharmaceuticals in Malaysia. It evaluates and approves drug applications, monitors adverse effects, and enforces compliance with regulatory standards. By overseeing drug registration, NPRA protects public health and facilitates access... Read More
Drug registration in Malaysia involves several steps: submission of a dossier to the National Pharmaceutical Regulatory Agency (NPRA), evaluation of safety, efficacy, and quality, Good Manufacturing Practice (GMP) inspection, product classification, and approval. Post-approval, the product is listed in the Quest 3+... Read More
In Malaysia, drug registration is required for pharmaceutical products, including prescription and over-the-counter medications, traditional medicines, health supplements, and veterinary products. This process ensures safety, efficacy, and quality. The National Pharmaceutical Regulatory Agency (NPRA) oversees the registration, ensuring compliance with regulatory standards... Read More
In Malaysia, the drug registration process typically takes about 210 to 245 working days, depending on the type of application and completeness of the submitted documents. This timeline includes evaluation by the National Pharmaceutical Regulatory Agency (NPRA) and approval by the Drug... Read More